Emerging evidence has shown that vitamin D deficiency may be related with community-acquired pneumonia (CAP), but individually published studies showed inconclusive results. The aim of this study was to quantitatively summarize the association between vitamin D and the CAP.
Introduction
Community-acquired pneumonia (CAP) is an infectious inflammation of lung parenchyma (including lung interstitium) occurring outside hospitals, which is one of the common infectious diseases threatening human health and is a nonnegligible problem during prevention and control of public health emergencies. The prevalence and incidence rates of CAP are linked to increasing age, especially among the elderly above age 65. The patients of CAP in the US was estimated to be 5.6 million every year, among which about 1.1 million patients that needed hospitalization. [1] The average in-hospital duration of CAP patients was 1 week in the US, the 30-day mortality rate was above 20%, and the mortality rate within 1 year of CAP patients after discharge was about 30%. [2] [3] [4] Besides, the clinical and economic burden of CAP is high over the world. For example, the costs of CAP in the Europe exceeded 10 billion Euro annually, with inpatient care accounting 5.7 billion, outpatient care 0.5 billion and drugs 0.2 billion. [5] [6] [7] About 60% of CAP patients were treated outpatient and the costs were low, however, the 40% of CAP patients admitted were faced with high mortality rate and medical costs, and the death rates of CAP patients during in-hospital treatment were far higher than other causes of death and ranked second among all in-hospital patients [8] With the developing of aging population recent decades, the hospitalization rate and death rate of CAP patients above age 65 are rising. [9] Recently, much attention has been paid to the role of vitamin D in host defense against infection. Apart from its classic function in calcium-phosphate homeostasis, vitamin D has pleiotropic immunomodulatory properties. It is reported that the vitamin D plays an important role in the innate immune response, particularly by increasing the production of antimicrobial peptides (B-defensing, cathelicidin). 10 Furthermore, vitamin D has been found to be of great effect on the activity of the adaptive immune system. [10] And several studies have shown an association between vitamin D deficiency (VDD) and increased the susceptibility to respiratory tract infections. [11] [12] [13] [14] [15] One study has investigated the relationship between 25-hydroxyvitamin D (25-(OH) D) levels and clinical outcome in CAP adults. [16] Berry et al found that vitamin D levels were associated with the incidence rate of respiratory tract infections, or namely the incidence rate of respiratory tract infections dropped by 7% when the serum 25-(OH) D3 level increased by 10 nmol/L. [12] Another retrospective study showed the possibility of hospitalization due to CAP rose when the serum 25-(OH) D3 level was < 37 nmol/L. [17] These studies all imply VDD may be the potent cause of CAP. However, Remmelts et al found an opposite conclusion that vitamin D did not reduce the incidence rate of pneumonia, and vitamin D supplementation even would raise the incidence of pneumonia without the medication of steroid hormones. [18] When 162 respiratory tract infection (RTI) adults were randomly given 12 weeks of vitamin D (2000U/d) or placebo, the serum vitamin D levels in the test group significantly rose, but the RTI was not significantly improved. [19] Another study in Canada showed the vitamin D level was not significantly related with the hospitalization of RTI children. [20] Up to present, there is more and more evidence indicating the association between vitamin D deficiency with communityacquired pneumonia. But these studies researching on the relationship of vitamin D and community-acquired pneumonia showed inconclusive results. Hence, we performed this metaanalysis to quantitatively summarize the association between vitamin D and the CAP, in order to provide some scientific suggestions for prevention of CAP.
Methods

Search strategy and selection criteria
Literatures on PubMed, Medline, Medline, Cochrane and EMBASE were systematically searched up till 31 September 2018 for relevant articles using the following keywords 'vitamin D' or 'cholecalciferol' or '25-hydroxyvitamin D' or '25(OH)D' in combination with 'community-acquired pneumonia' or 'CAP' or 'pneumonia' with no limitations. We also manually searched all eligible original articles, reviews and other relevant articles. And we contacted relevant authors by emails if necessary. This meta-analysis was performed following the guidelines for Meta-analysis of Observational Studies in Epidemiology (MOOSE). [21] No ethical approval is needed, for the reason that this study is a meta-analysis.
Inclusion and exclusion criteria
Original articles exploring the association between serum vitamin D status and CAP were reviewed and selected following these inclusion criteria:
1. the study population was human; 2. serum was sampled for assays of vitamin D levels; 3. CAP was the outcome and the control group consisted of people without CAP; 4. the sample size, the odd ratios (ORs) and their corresponding 95% confidence intervals (CIs) of the study were available; 5. vitamin D deficiency (VDD), vitamin D insufficiency (VDI) and severe vitamin D deficiency (SVDD) were defined as 10 to 20 ng/mL, 20 to 30 ng/mL, and <10 ng/mL 25(OH)D, respectively [22] ; 6. studies published in English; Animal experiments, chemistry, cell-line studies and editorials, review studies, commentaries, opinions and case reports were excluded.
Two authors independently assessed all literature searches and obtained full articles for all citations meeting the selection criteria. Final inclusion or exclusion decisions were made after reading the full articles carefully. A third author was participated in the literature searches to get a consensus when disagreement disappeared.
Quality assessment
In order to assess the quality of studies in this meta-analysis, the predefined methodological quality assessment criteria for observational studies was used. We assessed the quality of these studies with a checklist, adapted from Taggart et al, [23] using participants selection, comparability of groups at baseline, and how the diagnosis of CAP was made and according to what definition (see Table S1 , Supplemental Content, http://links.lww. com/MD/D245, which illustrates the Quality assessment of observational studies). We excluded any study that did not score in any item or a total score <7 out of 10 maximal points. [24] We used the design and sample size of studies to score for heterogeneity. Two authors (LLQ and YFZ) were responsibility for the extraction data independently, and the third author (BAL) took part in to reach a consensus when any differences occurred.
Data extraction
Data were extracted independently by two authors, and crosschecked by a third author using a standardized data extraction form. This information of each study was extracted carefully: the name of first author, publication year, location, study design, sample size, vitamin D assay method, vitamin D concentration, prevalence of vitamin D deficiency, and potential confounding factors included in the adjustments. In case of relevant data missing, the main authors were contacted for more information.
Statistical analysis
This meta-analysis was performed on RevMan 5.3 (Cochrane Collaboration, London, UK). The relationship of vitamin D levels and CAP were evaluated as ORs and weighted mean difference (WMD). If the OR and 95% CI were not available, the 2 Â 2 tables were used to obtain the value of OR and 95%CI. Data reported as median and range was converted to mean and standard deviation (SD). [25] Forest plots were used to evaluate the pooled estimates and corresponding 95% CIs for each study. The I 2 statistical test was performed to assess the heterogeneity in this meta-analysis. According to the I 2 statistical test, there were low (I 2 < 25%), moderate (near 50%) and high heterogeneity (> 75%). In case of heterogeneity (I 2 > 50%), a random-effects model was used; otherwise, the fixed-effects model was used in this meta-analysis. The sensitivity analyses were conducted to explore potential factors that may introduce heterogeneity into the results, and to investigate the effect of a single article on the overall risk estimated by removing one article in each turn. In this study, the Medicine P < .05 was considered significant. Publication bias was also conducted to explore potential factors by the funnel plots.
Results
Description of studies
A total of 623 articles were initially identified through the systematic literature search, and 47 full articles were read after screening the abstracts. Of these, 7 reviews and 22 studies not meeting the inclusion criteria were excluded. In addition, 6 studies were excluded for the reason of insufficient data. Finally, 8 articles [26] [27] [28] [29] [30] [31] [32] [33] were included after the strict screening. A flow chart showing the selecting process is summarized in Figure 1 .
According to the predefined methodological quality assessment criteria for observational studies, [23] [24] the quality scores of these studies ranged from 8 to 10, indicating all the included studies were of high quality (see Table S2 , Supplementary Content, http://links.lww.com/MD/D245, which illustrates the quality scores of included studies).
Characteristics of the included articles are summarized in Table 1 . Among the 8 articles, there were 4 case-control studies, 2 retrospective studies, one cross-sectional study and one prospective study. And these studies were published from 2010 to 2018 and reflected 6 countries. Four assay techniques were used to measure vitamin D levels. Among these included studies, 6 studies explored the relationship between VDD and CAP, [27] [28] [29] [30] [32] [33] 5 studies researched the relationship between VDI and CAP, [26, [28] [29] [32] [33] and 5 other studies discussed the relationship between SVDD and CAP. [28, [30] [31] [32] [33] Meanwhile, only 6 of the 8 studies explored the mean difference in serum vitamin D levels between CAP and non-CAP. [26, [29] [30] [31] [32] [33] The diversities of participant characteristics were considerable in these studies. A total of 20,966 participants were consisted of various ethnicities. Age ranged from 3 days to 94 years old, and the prevalence of VDD, if provided by studies, ranged from 33.9% to 65.1%. Seven of the 8 studies were conducted in adjustments of age, BMI, gender, smoking and other factors. More detailed information of included studies was presented in Table 1 . 
The relationships between vitamin D status and the risk of CAP
The relationships between vitamin D status and CAP are shown in Figures 2-4 . Random effect model showed that the association between vitamin D deficiency (VDD) and CAP was significant with high heterogeneity (OR = 1.64, 95%CI: 1.00, 2.67, I 2 = 89%) ( Fig. 2) . Besides, random-effects meta-analysis revealed the association with CAP was not significant for vitamin D insufficiency (VDI), with high heterogeneity (OR = 1.37, 95% CI: 0.81, 2.32, I 2 = 88%) ( Fig. 3) , and significant for severe vitamin D deficiency (SVDD), with high heterogeneity (OR = 6.65, 95%CI: 2.58, 17.15, I 2 = 90%) ( Fig. 4) . The comparison of mean difference between CAP group and non-CAP group is shown in Figure 5 . Based on 6 studies, the pooled effect was À5.63 ng/mL (95% CI: À9.11, À2.14) with high heterogeneity (I 2 = 95%, P < .01), which showed that there was statistically significant difference in vitamin D levels between CAP group and non-CAP group.
Sensitivity analysis
Sensitivity analyses were conducted to examine the potential sources of heterogeneity in this meta-analysis. In the results of the WMD, Li's study conducted in China [33] was responsible for most of the heterogeneity in this meta-analysis. After excluding this study, the heterogeneity was down to 75% and the WMD was À4.56 (95% CI: À6.40, À2.71). Further exclusion of any single study did not alter the overall combined relative risk, and each outcome had statistical significance. And Quraishi study [28] conducted in Brazil was responsible for most of the heterogeneity in the result of the ORs in this meta-analysis (OR = 1.97, 95% CI: 1.38, 2.81, I 2 = 61%). Besides, there were no obvious changes in Table 1 Characteristics of observational studies included in this meta-analysis. [28] Brazil Crosssectional 16975 321 Self-report Radioimmunoassay 33.9 NA NA Yes Age, sex, race, poverty-toincome ratio, and geographic location), clinical data (body massindex, smoking status, asthma, chronic obstructive pulmonary disease, congestive heart failure, diabetes mellitus, stroke, chronic kidney disease, neutropenia, and alcohol consumption, and season Jovanovich [29] USA [33] China Case-control 1582 797 Clinical findings CI 36 19.0 ± 9. 
Publication bias
No obvious publication bias was observed in the funnel plots of this meta-analysis (see Figure S1 , Supplementary Content, http:// links.lww.com/MD/D245, which illustrates the publication bias in this meta-analysis).
Discussion
This is the first meta-analysis on the relationship between serum vitamin D status and CAP among people. The results of 8 observational studies provide strong evidence that serum 25(OH) D level is associated with CAP. Both the results of the pooled ORs and the pooled effect of WMD showed that the serum 25(OH)D levels had a relationship with CAP. VDD experienced a significantly increased risk of CAP (OR = 1.64, 95%CI: 1.00, 2.67). People with CAP, compared to the control, were with the decreased level of vitamin D by 4.56 ng/mL. Considering the prevalence of vitamin D deficiency among humans, this result may provide some scientific suggestions for prevention of CAP.
According to the results of quality assessment, studies included in this meta-analysis were with high quality. Besides, there was no obvious publication bias after the analysis of funnel plots. The results of sensitivity analyses implied 2 studies probably contributed to the heterogeneity. [28, 30] After these 2 studies were excluded, low heterogeneity was found. Other heterogeneity might result from different vitamin D measuring methods, different sample time, and the differences among the study populations. Hence, more studies are needed to give full proof.
Vitamin D plays an important role in the CAP. As we known, the cause of CAP is associated with both pathogen infection and immune dysfunction. Vitamin D could considerably exert immune functions, so the level of vitamin D may be a susceptible factor of CAP. So far, the relationship between VD and CAP has been extensively studied. As reported by the US Centers for Disease Control and Prevention (CDC), when newborns with low vitamin D in vivo grow up to 1 year old, they have 6 times higher risks of suffering lung infections than infants with normal vitamin D levels. [34] Another random control-case study showed when 1to 36-month-old pneumonia infants orally took a single highdose of vitamin D3 (100,000 IU), recurrence was basically not found within 3 months. [35] Vitamin D may play two roles in the occurrence of CAP. 1) Vitamin D takes effect through the binding between its activated form 1, 25-(OH)2D3 and the vitamin D receptor (VDR). VDR can stimulate the expression of antibacterial peptides that resist bacterial and viral infections. [36] VDD causes the reduction of VDR level in vivo and thereby the denaturation, cornification and proliferation of respiratory tract mucous membrane epithelia, damaging their clearance function and the accumulation of nonneutralized proinflammatory media; consequently, the inflammatory reactions could not be controlled, leading to injured pulmonary tissues and blocked gas exchange. 2) Recent studies have confirmed the very important immunomodulatory functions that vitamin D could directly regulate the human inherent immunity and adaptive immunity, and which is closely related with respiratory infectious diseases, such as tuberculosis and CAP. [37] Vitamin D levels are significantly downregulated in critically ill patients with acute severe pneumonia or sepsis and are correlated with prognosis. [31, 38] In case of pulmonary infection, the pulmonary endothelial cells can convert the inactive vitamin D into its active form, and stimulate the expression of antibacterial peptides, thereby resisting infection. [39] Moreover, vitamin D deficiency is directly correlated with lung function injuries and is one independent risk factor of pneumonia. [40] Thus, vitamin D level affects not only the occurrence of lung diseases, but also the severity of CAP. Supplement with vitamin D might be able to reduce the occurrence and the severity of CAP.
There have a few limitations in this study. First, different methods were used to assess vitamin D levels. Second, the relationships from this meta-analysis between vitamin D and CAP might be affected by confounding factors, such as race, age and body mass index. Third, only published articles were included. Finally, vitamin D levels are still affected by the unapproved immunomodulatory reference intervals, season, sunlight, and races. Thus, stricter and normalized double-blind large-size studies are still needed.
Conclusion
The evidence presented here indicates an association between VDD and an increased risk of CAP, as person with < 20 ng/mL serum vitamin D is under increased risk of CAP (OR = 1.64, 95% CI: 1.00, 2.67). However, more evidence is needed to better understand the effect of vitamin D on the CAP, and well-designed trails are required to determine the explicit effect of vitamin D supplementation. Therefore, people at risk of VDD and determining how to supplement vitamin D could be considered in the future.
